跳至主要内容
临床试验/NCT00518934
NCT00518934Unknown1 期

Study for Safety and Efficiency of Therapeutic Angiogenesis for Patients With Limb Ischemia by Transplantation of Human Cord Blood Mononuclear Cell

Samsung Medical Center2 个研究点 分布在 2 个国家开始时间: 2007年8月21日最近更新:
适应症

试验速览

阶段
1 期
试验地点
2

研究概览

简要总结

The purpose of this study is to analyze the safety and efficiency of therapeutic angiogenesis for patients with limb ischemia by transplantation of human cord blood mononuclear cells.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
— 至 60 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with ischemic symptoms such as claudication, rest pain or nonhealing ischemic wound
  • Without evidence of improvement in response to conventional medical therapy
  • Not candidates for surgical intervention or radiologic intervention

排除标准

  • Malignant disease
  • More than 60 years old
  • Other significant medical conditions, including diabetes mellitus, hypertension, hyperlipidemia, etc.

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验

Study for Safety and Efficiency of Therapeutic... | 临床试验